Search

UAE

BTCS Reports Record Revenue for the Third Quarter 2025

Revenue Increases 568% Year-over-Year and 78% Sequentially to $4.94 Million Q3 2025 Net Income Reaches $65.59 Million Driven by Ethereum Accumulation ETH Holdings Increased to 70,322, Valued at $291.58 Million as of 9/30/25 Launched Imperium and Successfully Integrated Aave to

NeOnc Technologies Reports Updated Clinical Results

Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing novel brain-penetrant therapeutics for patients with malignant brain tumors and central nervous system (CNS) disorders, today announced that

مجموعة أسياد تستعرض حلولها اللوجستية المتكاملة لسلاسل إمداد الطاقة خلال مؤتمر أديبك 2025

من البنية الأساسية للموانئ العميقة إلى أسطول متنوّع من الناقلات والسفن ودعم حلول الوقود النظيف، تقدّم مجموعة أسياد نموذجًا متكاملًا خلال معرض ومؤتمر أديبك 2025 Asyad at ADIPEC 2025 أبو ظبي, Nov. 04, 2025 (GLOBE NEWSWIRE) — تشارك مجموعة أسياد،